Comment by yojo
Comment by yojo 7 days ago
The argument I’ve heard is it specifically makes investing in speculative software (new product lines, new features, etc) more expensive.
If you’re doing new drug discovery at a bio-lab, treating all your failures as depreciating “assets” seems bonkers. The same seems true of much software development where the work product ends up thrown away.
How does this compare to a machine that breaks and is thrown away before its amortization is complete? For the machine can you immediately deduct the remaining amount or is it required to continue to spread the value over the original time period?
I would imagine software that is thrown away should be similar?